Cannabidiol as a potential new type of an antipsychotic. A critical review of the evidence
Cathrin Rohleder, Juliane K. Mueller, Bettina Lange and 1 more
Frontiers in Pharmacology · 2016
doi:10.3389/fphar.2016.00422 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
References118
40 more references, whose wording the paper’s licence keeps private.
All 118 referencesCited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.